Emily Chu

Emily Chu has a work experience spanning over 10 years. Emily started their career as a Medical Writer at ESP Bioscience in 2011 and worked there until 2013. Later, they worked as a Freelance Scientific Proofreader at Proof-Reading-Service.com Ltd from 2013 to 2014. In 2014, they joined Thrombosis Research Institute as a Medical Writer and stayed until 2017. Currently, they are working at Envision Pharma Group, where they started as a Senior Medical Writer in 2018 and now holds the position of Scientific Director since January 2022.

Emily Chu obtained a Bachelor of Science degree in Biology from Imperial College London between 2000 and 2003. Following this, they pursued a PhD in Endocrinology at Queen Mary University of London from 2003 to 2007.